Anticoagulation practices in total pancreatectomy with autologous islet cell transplant patients: an international survey of clinical programs
Transpl Int
.
2021 Mar;34(3):593-595.
doi: 10.1111/tri.13821.
Epub 2021 Feb 9.
Authors
Chirag S Desai
1
,
Kristen R Szempruch
2
,
Jennifer S Vonderau
1
,
Mikael Chetboun
3
,
Francois Pattou
3
,
Toby Coates
4
,
Diedert Luc De Paep
5
,
Wayne J Hawthorne
6
,
Khalid M Khan
7
,
Eelco J P de Koning
8
,
Bashoo Naziruddin
9
,
Andrew Posselt
10
,
Beth A Schrope
11
,
Martin Wijkstrom
12
,
Piotr Witkowski
13
,
A M James Shapiro
14
Affiliations
1
Department of Surgery, Abdominal Transplant, Chapel Hill, NC, USA.
2
Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
3
Department of General and Endocrine Surgery, CHU Lille and European Genomic Institute for Diabetes, University of Lille, Lille, France.
4
Royal Adelaide Hospital, Adelaide, SA, Australia.
5
Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
6
Department of Surgery, Western Clinical School, Westmead Hospital, University of Sydney, Westmead, NSW, Australia.
7
Georgetown University Medical Center, Washington, DC, USA.
8
Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
9
Baylor University Medical Center, Dallas, TX, USA.
10
University of California San Francisco, San Francisco, CA, USA.
11
Columbia University Medical Center, New York, NY, USA.
12
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
13
University of Chicago, Chicago, IL, USA.
14
Clinical Islet Transplant Program and Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
PMID:
33452835
DOI:
10.1111/tri.13821
No abstract available
Publication types
Letter
MeSH terms
Anticoagulants / therapeutic use
Humans
Islets of Langerhans Transplantation*
Islets of Langerhans*
Pancreatectomy
Transplantation, Autologous
Substances
Anticoagulants